Effective Letermovir Prophylaxis of CMV infection post allogeneic hematopoietic cell transplantation: Results from the French temporary authorization of use compassionate program-Reference-Cited by-同舟云学术

Effective Letermovir Prophylaxis of CMV infection post allogeneic hematopoietic cell transplantation: Results from the French temporary authorization of use compassionate program

Published:2022-03 Issue: Volume:148 Page:105106
ISSN:1386-6532
Container-title:Journal of Clinical Virology
language:en
Short-container-title:Journal of Clinical Virology

Author:

Beauvais David^ORCID,Robin Christine,Thiebaut Anne,Alain Sophie,Coiteux Valérie,Ducastelle-Lepretre Sophie,Marçais Ambroise,Ceballos Patrice,Xhaard Alienor,Redjoul Rabah,Nguyen Stéphanie,Brissot Eolia,Joris Magalie,Turlure Pascal,Rubio Marie-Thérèse,Chevallier Patrice,Bénard Nathalie,Liautard Camille,Yakoub-Agha Ibrahim

Publisher

Elsevier BV

Subject

Infectious Diseases,Virology

Reference40 articles.

1. Seroprevalence of cytomegalovirus infection in the United States, 1988-1994;Staras;Clin. Infect. Dis.,2006

2. Cytomegalovirus seroprevalence in the United States: the national health and nutrition examination surveys, 1988-2004;Bate;Clin. Infect. Dis.,2010

3. Factors influencing cytomegalovirus seropositivity in stem cell transplant patients and donors;Ljungman;Haematologica,2007

4. Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis;Teira;Blood,2016

5. Burden of cytomegalovirus disease in allogeneic hematopoietic cell transplant recipients: a national, matched cohort study in an inpatient setting;Hakimi;Curr Res Transl Med,2018

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytomegalovirus in haematopoietic cell transplantation - The troll is still there;Best Practice & Research Clinical Haematology;2024-09

2. Real-world experience with letermovir for cytomegalovirus-prophylaxis after allogeneic hematopoietic cell transplantation: A multi-centre observational study;Journal of Infection;2024-08

3. Real-Life Data on the Efficacy and Safety of Letermovir for Primary Prophylaxis of Cytomegalovirus in Allogeneic Hematopoietic Stem Cell Recipients: A Single-Center Analysis;Turkish Journal of Hematology;2024-03-04

4. Risk factors for hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation in a letermovir‐exposed CMV‐free population receiving PTCy;European Journal of Haematology;2024-01-06

5. Efficacy and safety of letermovir prophylaxis for cytomegalovirus infection after hematopoietic stem cell transplantation;Blood Science;2024-01